DRD2 and schizophrenia: The therapeutical effect of this agonist could be related to the dopamine D2 receptor, considering they are colocalized in many areas of interest to schizophrenia in the brain such as olfactory tubercles, basal ganglia, thalamus, hypothalamus, and substantia nigra, and it has been proven that they can interact in native tissue [25].